Myofibroblasts. II. Intestinal subepithelial myofibroblasts

Area of Science:

• Gastroenterology
• Cell Biology
• Oncology

Background:

• Intestinal subepithelial myofibroblasts (ISEMF) are key cells in the intestinal lining.
• They respond to growth factors like platelet-derived growth factor (PDGF) and stem cell factor (SCF).
• ISEMF are involved in intestinal development and wound healing.

Purpose of the Study:

• To investigate the multifaceted roles of ISEMF in intestinal physiology and pathology.
• To explore the involvement of ISEMF in diseases such as Crohn's disease, collagenous colitis, and colon cancer.
• To examine the potential of targeting ISEMF-related pathways, like cyclooxygenase-2 (COX-2), for therapeutic interventions.

Main Methods:

• The study reviews existing research on ISEMF functions.
• It discusses the molecular mechanisms underlying ISEMF activation and signaling pathways (e.g., PDGF receptors, c-kit).
• It analyzes the involvement of ISEMF in ion secretion, fluid transport, and prostaglandin synthesis.

Main Results:

• ISEMF contribute to epithelial restitution and intestinal wound repair.
• They play a role in regulating intestinal ion and fluid transport through mechanisms like forming a hypertonic subepithelial compartment.
• Activation of cyclooxygenase (COX)-1 and COX-2 by ISEMF influences intestinal secretion.
• Paracrine secretion of growth factors (e.g., transforming growth factor-beta) by ISEMF may impact colonic tumorigenesis and metastasis.
• COX-2 in polyp ISEMF is a potential target for nonsteroidal anti-inflammatory drugs (NSAIDs), explaining their effects in familial adenomatous polyposis and sporadic colon neoplasms.

Conclusions:

• ISEMF are pleiotropic cells with significant roles in intestinal health and disease.
• Further research is needed to fully elucidate the complex functions of ISEMF.
• Targeting COX-2 in ISEMF presents a potential therapeutic strategy for colorectal neoplasms.